This study was received prior approval from the Ethics Committees of Showa University and Tokyo University of Pharmacy and Life Sciences. Informed consent was obtained from a total of 98 participants prior to their enrollment. Blood was drawn from 70 patients with acute coronary syndrome (ACS), admitted within 4 hours after onset to Showa University Hospital for emergency coronary catheterization (42 men, 28 women; aged 22-88); 28 healthy volunteers (17 men, 11 women; aged 21-56) were also recruited. ACS patients included 53 with acute myocardial infarction and 17 with unstable angina pectoris.
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Buffered 10% formalin-fixed paraffin-embedded human coronary artery specimens from archive collections of the National Cerebral and Cardiovascular Center were used for immunohistochemistry. Serial cross-sections (3-4 μm) of coronary arteries from 14 patients with CAD (aged 60-87) and 4 patients with dilated cardiomyopathy (as non-CAD examples) (aged 19-39) were stained with polyclonal rabbit antibody against human KP-10 or its receptor GPR54 (LifeSpan BioSiences) as described previously.
2,3

Supplemental Results
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Expressions of KP-10 and GPR54 in Coronary Artery Lesions and Plasma in CAD Patients
Faint expressions of KP-10 and GPR54 were observed in the endothelium of normal coronary arteries from non-CAD patients ( Figure S2A: a, b) . KP-10 also was abundantly expressed in adventitia (Figure S2A: a) . In stenotic and obstructive coronary arteries from CAD patients, both KP-10 and GPR54 were expressed at high levels in the atheromatous plaques ( Figure S2A: c-h ). Both KP-10 and GPR54 expressions became greater in accordance with the severity of atheromatous plaques ( Figure S2A : c-h). In contrast, plasma KP-10 level tended to be reduced in CAD (ACS) patients compared with healthy volunteers ( Figure S2B ). We speculate that plasma KP-10 may be rapidly exhausted in thrombus formation in the coronary arteries within 4 hours after onset of ACS, because KP-10 is also known to act as an anti-coagulant and thrombolytic agent. 
